Thus, we tested IL-4 and IL-13 expressions, and based on these results, we found that SGD significantly increased IL-13 content, possibly triggering an M1-to-M2 phenotype transition involved in this protective process. The gene discussed is IL4; the disease is specific granule deficiency.